ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Demonstration project to yield useful data, Peter Bach says.

June 3, 2005

Eight Firms Join AACR As Sustaining Members

April 25, 1997

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

Eleven Chemicals Rated for Tests

September 1, 1978

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Funding Opportunities (8-page issue).

May 23, 2003